Open Access
| Issue |
BIO Web Conf.
Volume 228, 2026
Biospectrum 2025: International Conference on Biotechnology and Biological Science
|
|
|---|---|---|
| Article Number | 07003 | |
| Number of page(s) | 7 | |
| Section | Microbial Biotechnology | |
| DOI | https://doi.org/10.1051/bioconf/202622807003 | |
| Published online | 11 March 2026 | |
- L. Kumar, M. Bisen, K. Harjai, S. Chhibber, S. Azizov, H. Lalhlenmawia, D. Kumar, Advances in nanotechnology for biofilm inhibition, ACS Omega, 8, 21391–21409 (2023). [Google Scholar]
- K.W.K. Tang, B.C. Millar, J.E. Moore, Antimicrobial resistance (AMR), Br. J. Biomed. Sci., 80, 11387 (2023). [Google Scholar]
- R.M. Kariyawasam, D.A. Julien, D.C. Jelinski, S.L. Larose, E. Rennert-May, J.M. Conly, H.W. Barkema, Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021), Antimicrob. Resist. Infect. Control, 11, 45 (2022). [Google Scholar]
- Saniya, R. Divya, M. Sharmila, C. Prakash, Anti-diabetic and antimicrobial activities of Grona triflora medicinal plant, Arch. Tech. Sci., 1, 176–187 (2025). https://doi.org/10.70102/afts.2025.1732.176 [Google Scholar]
- EFSA Panel on Biological Hazards (BIOHAZ), K. Koutsoumanis, A. Allende, A. Álvarez-Ordóñez, D. Bolton, S. Bover-Cid, L. Peixe, Role played by the environment in the emergence and spread of antimicrobial resistance (AMR) through the food chain, EFSA J., 19, e06651 (2021). [Google Scholar]
- V. Costanzo, G.N. Roviello, the potential role of vaccines in preventing antimicrobial resistance (AMR): an update and future perspectives, Vaccines, 11, 333 (2023). [Google Scholar]
- S. Patil, A.D. Thimmappa, A. Tomar, A. Verma, Plant-based green synthesis of AgNPs and their structural and antimicrobial characterization, Nat. Eng. Sci., 10, 363–373 (2025). https://doi.org/10.28978/nesciences.1648765 [Google Scholar]
- Y. Wang, Z. Bian, Y. Wang, Biofilm formation and inhibition mediated by bacterial quorum sensing, Appl. Microbiol. Biotechnol., 106, 6365–6381 (2022). [Google Scholar]
- K. Tejesh, M. Thiru Chitrambalam, Y. Swarna Latha, B. Pattanaik, S.K. Manju Bargavi, R. Kushwaha, A. Dev, Assessment of nano-particles for the removal of bacteria and viruses from aquatic systems, Int. J. Aquat. Res. Environ. Stud., 5, 256–261 (2025). https://doi.org/10.70102/IJARES/V5I1/5-1-28 [Google Scholar]
- G. Liu, Q. Lin, S. Jin, C. Gao, The CRISPR-Cas toolbox and gene editing technologies, Mol. Cell, 82, 333–347 (2022). [Google Scholar]
- D. Zhang, G. Wang, X. Yu, T. Wei, L. Farbiak, L.T. Johnson, D.J. Siegwart, Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy, Nat. Nanotechnol., 17, 777–787 (2022). [Google Scholar]
- N. Kalter, C. Fuster-García, A. Silva, V. Ronco-Díaz, S. Roncelli, G. Turchiano, A. Hendel, Off-target effects in CRISPR-Cas genome editing for human therapeutics: progress and challenges, Mol. Ther. Nucleic Acids, (2025). [Google Scholar]
- F.L. van de Veerdonk, E. Giamarellos-Bourboulis, P. Pickkers, L. Derde, H. Leavis, R. van Crevel, M.G. Netea, A guide to immunotherapy for COVID-19, Nat. Med., 28, 39–50 (2022). [Google Scholar]
- Melcher, K. Harrington, R. Vile, Oncolytic virotherapy as immunotherapy, Science, 374, 1325–1326 (2021). [Google Scholar]
- Knight, L. Karapetyan, J.M. Kirkwood, Immunotherapy in melanoma: recent advances and future directions, Cancers, 15, 1106 (2023). [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.